Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2002PEDIATRICS

The Process of Public Policy Formulation: The Case of Thimerosal in Vaccines

View Full Paper
Ask AI
Bookmark
Share

Authors

GFGary L. FreedUniversity of MichiganMAMargie C. AndreaeHenry Ford Health SystemACAnne E. CowanUniversity of Michigan

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Freed et al. (2002) studied this question.

synapsesocial.com/papers/6a7b373802ab7a73dd034010https://doi.org/10.1542/peds.109.6.1153
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Impact of Recommendations to Suspend the Birth Dose of Hepatitis B Virus Vaccine2001 · 32 citations
  2. 2Universal Hepatitis B Immunization of Infants: Reactions of Pediatricians and Family Physicians Over Time1994 · 93 citations
  3. 3Safety of vaccinations. Miss America, the media, and public health1996 · 73 citations
  4. 4An Assessment of Thimerosal Use in Childhood Vaccines2001 · 340 citations